Objectives: To define the genetic basis of clarithromycin resistance among isolates of the Mycobacterium abscessus group (MAG).
Introduction
Isolates of the Mycobacterium abscessus group (MAG) are the most common rapidly growing mycobacteria isolated from patients with pulmonary infection. These environmental organisms are often opportunistic pathogens and have been associated with nosocomial infections, including outbreaks. [1] [2] [3] [4] [5] [6] [7] [8] Species classification of MAG isolates remains a controversial issue owing to considerable similarity between Mycobacterium bolletii and Mycobacterium massiliense. Based on DNA-DNA hybridization studies, Leão et al. 9, 10 have proposed that MAG be classified as a single species with two subspecies: M. abscessus subsp. abscessus and M. abscessus subsp. bolletii, the latter including both M. bolletii and M. massiliense. Other studies applying whole-genome analysis support the separation into three distinct species. [11] [12] [13] [14] Recently, Tortoli et al. 15 proposed that the species M. abscessus encompasses M. abscessus subsp. abscessus, M. abscessus subsp. bolletii and a third subspecies named M. abscessus subsp. massiliense comb. nov. Treatment of MAG infections is complicated by the high frequency of antibiotic resistance among the isolates. [16] [17] [18] Current guidelines identify clarithromycin and azithromycin as the primary agents used, but emphasize the need for multidrug treatment regimens to ensure effective therapy until susceptibility results are available. 19 Clarithromycin resistance in MAG can be mediated by several mechanisms. The erm(41) gene, which is widely prevalent among MAG, transfers one or two methyl groups to an adenine in the peptidyl region of 23S rRNA, and thereby prevents clarithromycin binding. [20] [21] [22] [23] Two alterations of erm(41) are independently associated with reversion to clarithromycin susceptibility: a 274 bp deletion 7 and a T28C point mutation. 8, [24] [25] [26] [27] [28] The rrl gene encodes the 23S rRNA peptidyl transferase; the A2058G mutation in rrl confers high levels of resistance to clarithromycin. [19] [20] [21] This study examined a collection of pulmonary MAG isolates for which species identification was resolved by rpoB sequencing; clarithromycin resistance phenotype was based on in vitro susceptibility testing with extended incubation; rrl and erm(41) genotypes were determined by sequence analysis; and the presence of deletions in erm(41) was assessed using PCR.
Materials and methods

Isolates
Among 635 pulmonary isolates submitted to the Tuberculosis and Mycobacteriosis Branch of Adolfo Lutz Institute from January 2010 to December 2011 for species identification, 153 (24.1%) were classified as MAG by PRA-hsp65 typing. 29 Of those, 134 were viable for analysis, including one isolate that by rpoB sequencing proved to be Mycobacterium porcinum, leaving 133 MAG isolates in the final study set.
Species identification
Definitive species identification was obtained by sequencing a fragment of the rpoB gene using Myco F (5 0 -GGCAAGGTCACCCCGAAGGG-3 0 ) and Myco R (5 0 -AGCGGCTGCTGGGTGATCATC-3 0 ) as primers. 30 The sequences were analysed with the software BioNumerics version 7.1 (Applied Maths, TX, USA) and the BLAST tool (http://blast.ncbi.nlm.nih.gov) was used to determine similarity with the following reference strains: M. abscessus ATCC 19977 (GenBank accession number JF346872), M. bolletii CIP 108541 (AY859692.1) and M. massiliense CIP 108297 (JX041985.1). The species classification reported for each study isolate represents the highest similarity score with the indicated reference strain. For simplification, the species M. abscessus subsp. abscessus, M. abscessus subsp. bolletii and M. abscessus subsp. massiliense are referred to as M. abscessus, M. bolletii and M. massiliense, respectively.
Clarithromycin susceptibility testing with resazurin
The MIC test was performed according to CLSI 31 recommendations, with clarithromycin concentrations from 0.5 to 64 mg/L and using Staphylococcus aureus ATCC 29213 as quality control. Replicate plates were prepared to provide readings after 3, 5, 7, 10 and 14 days of incubation, where 3 days represents the current standard recommendation and 14 days represents a proposed extended incubation. 30 At each timepoint 30 lL of 0.01% resazurin was added to each well and the plate reincubated overnight. 32 A change in colour from blue (oxidized state) to pink (reduced) indicates bacterial growth. The MIC value was defined as the lowest drug concentration that prevented growth, and isolates were classified as susceptible (S; MIC 2 mg/L) or resistant (R; MIC .2 mg/L). Isolates that met the criteria for susceptibility on day 3, but were classified as resistant subsequently, are reported as 'inducible resistance' (IR). 7, 27, 28 erm (41) and rrl gene sequencing
The primers for amplifying rrl were SP1 (CCTGCACGAATGCGGTAACG) and SP2 (CACCAGAGGTTCGTCCGTC). 7 The primers erm41f2 and erm41r2, described by Maurer et al., 7 were tested for amplification of the erm(41) gene. However, the amplified region did not contain the region where the mutation occurs. Consequently, the sequence to be amplified was analysed and the primer reverse was designed. The amplification and sequence analysis of erm (41) was performed using the following primers Forward (5 0 -GACCGGGGCCTTCTTCGTGAT-3 0 ) 7 and Reverse (5 0 -GGAGTTCGTTGTGGATCT GG-3 0 ). The resulting product, which includes 114 bp of the N-terminal coding region covering the T28C mutation 28 and the deletion at 64-65 bp, 33 was sequenced for all isolates. Sequence data were analysed with BioNumerics version 7.1 (Applied Maths, Sint-Martens-Latem, Belgium), using M. abscessus MAB30 (GenBank accession number EU590129) as the reference sequence for erm (41) , and M. abscessus (GenBank accession number NC_010397.1) for rrl.
PCR analysis of erm(41)
The entire erm(41) coding region was amplified using the protocol of Brown-Elliott et al. 34 and primers ermF (5 0 -GACCGGGGCCTTCTTCGTGAT-3 0 ) and ermR1 (5 0 -GACTTCCCCGCACCGATTCC-3 0 ). The presence of the characteristic deletions in erm(41) (2 bp, nucleotides 64-65; 274 bp, nucleotides 159-432) was identified from the reduced size of the PCR product (expected, 673 bp; deletions present, 397 bp) and confirmed for selected isolates by sequencing the entire coding region.
Results
Identification
Among the 133 MAG isolates in the study set, all 78 isolates designated M. abscessus type 1 by PRA-hsp65 typing were identified as M. abscessus. Of the 55 isolates of M. abscessus type 2, 27 were identified as M. massiliense, 24 as M. bolletii and 4 as M. abscessus.
Clarithromycin susceptibility testing
The proportion of isolates showing clarithromycin inducible resistance increased over the course of the extended incubation, with the sharpest increase observed between days 7 and 10 ( Figure 1) . At day 14, inducible resistance was similarly prevalent among isolates of both M. abscessus (84%) and M. bolletii (96%), but absent among M. massiliense (0%).
erm(41) and rrl gene sequencing
For all 133 isolates, the genotypes at erm(41) and rrl were compared with the results of clarithromycin susceptibility testing using the day 14 reading and the results of rpoB species identification ( Table 1) . Sequencing of rrl identified only a single isolate with the A2058G mutation; that isolate also had intact erm(41) and was resistant.
PCR analysis indicated the presence of deletions in erm(41) among 30 (83%) of the 36 clarithromycin-susceptible isolates, including all 27 M. massiliense. Of the six susceptible isolates without deletions, all were M. abscessus that carried the erm(41) T28C point mutation. Among the 97 resistant isolates, PCR indicated that all had an intact WT erm (41) . Based on these results, PCR detection of deletions in the erm(41) gene had excellent performance characteristics as a presumptive test for clarithromycin susceptibility: with sensitivity, 83%; specificity, 100%; positive predictive value, 100%; and negative predictive value, 94%.
The sequence analysis of the N-terminal region of erm(41) was compared with the subspecies assignment determined by rpoB. All M. bolletii isolates were clustered (.99.2% homology) as a distinct subset within M. abscessus, and both of those subspecies were readily distinguished from M. massiliense (,95% homology; data not shown). As expected, all the M. massiliense isolates were clustered (.98% homology) and all had the smaller erm(41) PCR product consistent with the characteristic deletions.
Clarithromycin susceptibility among M. abscessus group isolates JAC The M. massiliense cluster included three M. abscessus isolates (isolates 640, 979 and 1189), which also demonstrated the smaller PCR product. The sequences of the complete coding region of erm(41) for these isolates were identical to each other and to M. massiliense (isolate 2883). It is unclear whether the three isolates acquired the altered gene from M. massiliense or whether the same deletion process occurred independently.
Discussion
Among pulmonary infections associated with rapidly growing mycobacteria species, 80% are caused by MAG. 7, 17, 35, 36 The erm(41) gene, which is essentially universal among these organisms, mediates resistance to the macrolide clarithromycin and thereby greatly complicates effective treatment. 26, 28 Choi et al.
37
proposed that a large accumulation of erm (41) protein is required to effectively block the drug binding site and forms the basis for the high frequency of inducible resistance that is missed using the routine 3 day incubation and only detected with an extended 14 day incubation in the presence of the drug.
In this study of 133 pulmonary isolates of MAG, we performed replicate susceptibility tests with varying incubation periods ranging from 3 to 14 days to determine if IR could be reliably detected with shorter incubation, thereby providing a faster clinical result. The frequency of resistant phenotype after 3 days was ,5% and increased steadily through 14 days of incubation to .70%, indicating the need for that entire period. This high rate of IR is consistent with other studies [38] [39] [40] and supports the need to modify the clarithromycin susceptibility testing protocol currently recommended by CLSI. 31 An incubation period of .14 days was not evaluated in this study; however, Christianson et al. 41 tested a prolonged incubation of 21 days for 14 M. abscessus isolates that were susceptible at day 14. Of these isolates, only one presented an MIC " 8 mg/L, but the authors concluded that there is no additional value to adding a 21 day reading to the test. They also tested Mycobacterium chelonae isolates that have no inducible resistance to clarithromycin to verify the stability of this drug. The isolates were incubated for 21 days, and all of them were susceptible. The authors concluded from these results that the clarithromycin was sufficiently active over the entire 21 day incubation period. WT  96  -92  4  72  24  -A2058G  WT  1  --1  1  --WT  deletions   b   30  30  --3  -27  WT  T28C  6  6  --6  --A2058G  T28C  0  ---- de Carvalho et al.
We further analysed the genotypes of the isolates using sequencing of rpoB to identify the species within MAG, sequencing of erm(41) to detect both a point mutation (T28C) and deletions associated with gene inactivation, and sequencing of rrl to detect the A2056G mutation associated with clarithromycin resistance.
The species classification reported for each study isolate represents the highest similarity score compared with the indicated reference strain. Despite the cut-off value 97% for species differentiation proposed by McNabb et al., 42 we considered the similarity score 99%, as species belonging to MAG have only 1.46% divergence in rpoB sequences. 43 Species identification indicated that both M. abscessus and M. bolletii isolates demonstrated high frequency of inducible resistance. In contrast, M. massiliense isolates were uniformly susceptible even after extended incubation and this was consistently associated with previously defined inactivating deletions. These observations are consistent those of Maurer et al. 44 and Mougari et al. 45 Analysis of erm (41) and rrl genotypes with susceptibility phenotypes was also revealing. Of the 133 isolates studied, 36 (27%) were susceptible. Among those, 30 (83%) had erm(41) deletions, including all 27 M. massiliense and three M. abscessus. The remaining six (17%) susceptible isolates were M. abscessus with the erm(41) T28C mutation. Of note, the A2058G mutation in rrl was detected in only a single isolate in the collection; that isolate was resistant, but also had WT erm (41) .
Finally, we applied PCR to erm(41) and consistently detected a shortened PCR product in isolates documented to have the inactivating deletions. Specifically, all 30 isolates with sequenceconfirmed deletions in erm(41) were identified by PCR. These represented .80% of the susceptible isolates as determined by the extended 14 day incubation. We conclude that PCR provides a highly reliable method to detect inactivating deletions of the erm(41) gene and thereby rapidly identify the substantial majority of clarithromycin-susceptible MAG isolates and facilitate effective treatment. Some authors 14, 15, 33 have suggested that detecting deletions of the erm(41) gene may effectively differentiate M. massiliense from M. abscessus and M. bolletii. Our results appear consistent with this possibility. Of the 30 isolates in this report with a deletion in the erm(41) gene, three (10%; 95% CI: 2.1%-26.5%) were identified as subspecies M. abscessus. We believe that a substantially larger study is needed to define more precisely the reliability of erm(41) deletions for identification of M. massiliense subspecies.
In conclusion, this study verified that the clarithromycin susceptibility test with extended incubation for up to 14 days identified inducible resistance in 69.2% of MAG isolates that appeared susceptible by the standard 3 day incubation currently recommended. 31 Together, erm(41) and mutations in rrl currently represent the best defined mechanisms of macrolide resistance among MAG isolates. Sequencing confirmed that the most frequent and consistent correlate of susceptibility was the presence of previously identified inactivating deletions in erm (41) . Further, those deletions were reliably demonstrated by PCR, which yielded a smaller amplification product readily distinguished from that of intact WT genes. These results suggest that in the management of infections due to MAG, a simple, rapid PCR assay might be more efficient than in vitro susceptibility testing.
